SCHEMBL6915520

SCHEMBL6915520

O=c1[nH]ccc2cc([C@@H]3OC(CO)C(O)C3O)oc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYNJ2 O15056 1/20 0.41
L3MBTL1 Q9Y468 4/20 0.40
CYP1A2 P05177 1/20 0.40
KDM4E B2RXH2 5/20 0.40
ALDH1A1 P00352 4/20 0.40
GAA P10253 3/20 0.40
APEX1 P27695 3/20 0.40
MEN1 O00255 2/20 0.40
POLB P06746 2/20 0.40
KMT2A Q03164 2/20 0.40
TDP1 Q9NUW8 2/20 0.40
MAPT P10636 1/20 0.40
THRB P10828 1/20 0.40
SLC5A2 P31639 1/20 0.38
MGAM O43451 1/20 0.38
GUSB P08236 1/20 0.38
MMP9 P14780 1/20 0.38
ALPI P09923 1/20 0.38
ALPG P10696 1/20 0.38
HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6915512 1.00 SYNJ2 (0.41) SYNJ2L3MBTL1CYP1A2KDM4EALDH1A1
SCHEMBL4293687 0.75 KDM4E (0.49) SYNJ2L3MBTL1CYP1A2KDM4EALDH1A1
SCHEMBL16620686 0.72 SLC5A2 (0.40) ALDH1A1SLC5A2PYGL
SCHEMBL9293545 0.72 SLC5A2 (0.40) ALDH1A1SLC5A2PYGL
SCHEMBL1022027 0.72 SLC5A2 (0.40) ALDH1A1SLC5A2PYGL
SCHEMBL1998975 0.72 SLC5A2 (0.40) ALDH1A1SLC5A2PYGL
SCHEMBL13317068 0.70 SLC5A2 (0.57) SLC5A2
SCHEMBL3786766 0.69 SLC5A2 (0.47) CYP1A2KDM4EALDH1A1MAPTSLC5A2
SCHEMBL1444855 0.69 SLC5A2 (0.47) CYP1A2KDM4EALDH1A1MAPTSLC5A2
SCHEMBL7024599 0.69 SLC5A2 (0.47) CYP1A2KDM4EALDH1A1MAPTSLC5A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040122223-A1 Non-natural nucleotides and dinucleotides CELLTECH R & D LIMITED (GB) 2004-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040122223-A1 Non-natural nucleotides and dinucleotides P2RY1, P2RY11, P2RY13 SYNJ2 1378/4885L3MBTL1 4753/4885CYP1A2 3409/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.